Works by Bang, Soo-Mee

Results: 99
    1
    2

    Association of TP53 Mutation Status and Sex with Clinical Outcome in Non–Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Cohort Study.

    Published in:
    Cancer Research & Treatment, 2025, v. 57, n. 1, p. 70, doi. 10.4143/crt.2024.046
    By:
    • Choi, Songji;
    • Kim, Se Hyun;
    • Lee, Sejoon;
    • Seo, Jeongmin;
    • Kang, Minsu;
    • Jung, Eun Hee;
    • Kim, Sang-A;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Ji-Won;
    • Kim, Jin Won;
    • Lee, Jeong-Ok;
    • Kim, Yu Jung;
    • Lee, Keun-Wook;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok
    Publication type:
    Article
    3
    4
    5

    Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.

    Published in:
    International Journal of Hematology, 2021, v. 113, n. 1, p. 81, doi. 10.1007/s12185-020-02988-6
    By:
    • Lee, Ho Sup;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Yoon, Dok Hyun;
    • Lee, Yoojin;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Jo, Jae-Cheol;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Kim, Sung-Hyun;
    • Kim, Min Kyoung;
    • Lim, Sung-Nam
    Publication type:
    Article
    6
    7
    8

    Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients.

    Published in:
    International Journal of Hematology, 2014, v. 100, n. 2, p. 141, doi. 10.1007/s12185-014-1617-8
    By:
    • Kim, Soo-Jeong;
    • Cheong, June-Won;
    • Kim, Dae-Young;
    • Lee, Je-Hwan;
    • Lee, Kyoo-Hyung;
    • Kim, Yeo-Kyeoung;
    • Kim, Hyeong-Joon;
    • Song, Ik-Chan;
    • Jo, Deog-Yeon;
    • Lee, Jeong-Ok;
    • Bang, Soo-Mee;
    • Park, Jinny;
    • Lee, Jae;
    • Lee, Won-Sik;
    • Joo, Young-Don;
    • Maeng, Chi;
    • Yoon, Hwi-Joong;
    • Lee, Na-Ri;
    • Kwak, Jae-Yong;
    • Kim, Kyoung
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Nongastric marginal zone B-cell lymphoma: Analysis of 247 cases.

    Published in:
    American Journal of Hematology, 2007, v. 82, n. 6, p. 446, doi. 10.1002/ajh.20874
    By:
    • Oh, Sung Yong;
    • Ryoo, Baek-Yeol;
    • Kim, Won Seog;
    • Park, Yeon Hee;
    • Kim, Kihyun;
    • Kim, Hyun Jung;
    • Kwon, Jung Mi;
    • Lee, Jeeyun;
    • Ko, Young Hye;
    • Ahn, Yong Chan;
    • Oh, Suk Joong;
    • Lee, Soon Il;
    • Kim, Hyo-Jin;
    • Kwon, Hyuk-Chan;
    • Bang, Soo Mee;
    • Kim, Jung Han;
    • Park, Jinny;
    • Lee, Seung-Sook;
    • Kim, Ho Young;
    • Park, Keunchil
    Publication type:
    Article
    20
    21
    22
    23

    Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia.

    Published in:
    Leukemia & Lymphoma, 2011, v. 52, n. 6, p. 1024, doi. 10.3109/10428194.2011.563885
    By:
    • Sohn, Sang Kyun;
    • Oh, Suk Joong;
    • Kim, Byung Soo;
    • Ryoo, Hun Mo;
    • Chung, Joo Seop;
    • Joo, Young Don;
    • Bang, Soo Mee;
    • Jung, Chul Won;
    • Kim, Dong Hwan;
    • Yoon, Sung Soo;
    • Kim, Ho;
    • Lee, Hong Ghi;
    • Won, Jong Ho;
    • Min, Yoo Hong;
    • Cheong, June Won;
    • Park, Joon Seong;
    • Eom, Ki Seong;
    • Hyun, Myung Soo;
    • Kim, Min Kyoung;
    • Kim, Hawk
    Publication type:
    Article
    24

    Prognostic implications of the immunophenotype in biphenotypic acute leukemia.

    Published in:
    Leukemia & Lymphoma, 2008, v. 49, n. 4, p. 700, doi. 10.1080/10428190701843247
    By:
    • Lee, Je-Hwan;
    • Min, Yoo Hong;
    • Chung, Chul Won;
    • Kim, Byoung Kook;
    • Yoon, Hwi-Joong;
    • Jo, Deog-Yeon;
    • Shin, Ho-Jin;
    • Bang, Soo-Mee;
    • Won, Jong-Ho;
    • Zang, Dae Young;
    • Kim, Hyeoung Joon;
    • Chi, Hyun-Sook;
    • Lee, Kyoo-Hyung;
    • Cheong, June-Won;
    • Kim, Jin Seok;
    • Kim, Sun Hee;
    • Park, Seonyang;
    • Park, Su Yon;
    • Chung, Joo Seop;
    • Lee, Jae Hoon
    Publication type:
    Article
    25

    CHOP followed by involved field radiotherapy for localized primary gastric diffuse large B-cell lymphoma: Results of a multi center phase II study and quality of life evaluation.

    Published in:
    Leukemia & Lymphoma, 2006, v. 47, n. 7, p. 1253, doi. 10.1080/10428190600556239
    By:
    • Park, Yeon Hee;
    • Lee, Se-Hoon;
    • Kim, Won Seog;
    • Bang, Soo-Mee;
    • Ryoo, Baek-Yeol;
    • Yang, Sung Hyun;
    • Lee, Seung-Sook;
    • Kim, Mi Sook;
    • Kim, Kihyun;
    • Park, Keon Woo;
    • Im, Do Hyoung;
    • Kang, Jung Hun;
    • Lee, Jeeyun;
    • Ko, Young H.;
    • Ahn, Yong Chan;
    • Lim, Do Hoon;
    • Park, Keunchil
    Publication type:
    Article
    26
    27
    28
    29
    30

    Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome.

    Published in:
    PLoS ONE, 2016, v. 11, n. 11, p. 1, doi. 10.1371/journal.pone.0166245
    By:
    • Suh, Koung Jin;
    • Cheong, June-Won;
    • Kim, Inho;
    • Kim, Hyeoung-Joon;
    • Shin, Dong-Yeop;
    • Koh, Youngil;
    • Yoon, Sung-Soo;
    • Min, Yoo Hong;
    • Ahn, Jae-Sook;
    • Kim, Yeo-Kyeoung;
    • Lee, Yun-Gyoo;
    • Lee, Jeong-Ok;
    • Bang, Soo-Mee;
    • Mun, Yeung-Chul;
    • Seong, Chu-Myoung;
    • Park, Yong;
    • Kim, Byung-Soo;
    • Hong, Junshik;
    • Park, Jinny;
    • Lee, Jae Hoon
    Publication type:
    Article
    31

    Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.

    Published in:
    British Journal of Haematology, 2013, v. 161, n. 3, p. 339, doi. 10.1111/bjh.12256
    By:
    • Lee, Yun‐Gyoo;
    • Kim, Inho;
    • Yoon, Sung‐Soo;
    • Park, Seonyang;
    • Cheong, June Won;
    • Min, Yoo Hong;
    • Lee, Jeong‐Ok;
    • Bang, Soo‐Mee;
    • Yi, Hyeon Gyu;
    • Kim, Chul Soo;
    • Park, Yong;
    • Kim, Byung‐Soo;
    • Mun, Yeung‐Chul;
    • Seong, Chu‐Myoung;
    • Park, Jinny;
    • Lee, Jae Hoon;
    • Kim, Sung‐Yong;
    • Lee, Hong Ghi;
    • Kim, Yeo‐Kyeoung;
    • Kim, Hyeoung‐Joon
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 2995, doi. 10.1007/s00432-021-03872-4
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    38
    39

    Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS Study.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 1, p. 515, doi. 10.1007/s00277-024-05958-8
    By:
    • Fu, Weijun;
    • Bang, Soo-Mee;
    • Huang, Honghui;
    • Kim, Kihyun;
    • Li, Wei;
    • An, Gang;
    • Lee, Je-Jung;
    • Cai, Zhen;
    • Jin, Jie;
    • Wang, Yafei;
    • Chim, Chor Sang;
    • Carson, Robin;
    • Liu, Rui;
    • Zhao, Man;
    • Chen, Xi;
    • Cui, Canchan;
    • Hou, Jian;
    • Wang, Jianxiang
    Publication type:
    Article
    40

    Correction to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study.

    Published in:
    2024
    By:
    • Fu, Weijun;
    • Bang, Soo-Mee;
    • Huang, Honghui;
    • Kim, Kihyun;
    • Li, Wei;
    • An, Gang;
    • Lee, Je-Jung;
    • Cai, Zhen;
    • Jin, Jie;
    • Wang, Yafei;
    • Chim, Chor Sang;
    • Carson, Robin;
    • Liu, Rui;
    • Zhao, Man;
    • Chen, Xi;
    • Cui, Canchan;
    • Hou, Jian;
    • Wang, Jianxiang
    Publication type:
    Correction Notice
    41
    42
    43
    44
    45

    The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).

    Published in:
    2020
    By:
    • Jo, Jae-Cheol;
    • Lee, Ho Sup;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Yoon, Dok Hyun;
    • Lee, Yoojin;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Kim, Sung-Hyun;
    • Kim, Min Kyoung;
    • Lim, Sung-Nam
    Publication type:
    journal article
    46
    47

    Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party.

    Published in:
    Annals of Hematology, 2019, v. 98, n. 1, p. 151, doi. 10.1007/s00277-018-3495-2
    By:
    • Jung, Sung-Hoon;
    • Yang, Deok-Hwan;
    • Kim, Sung-Hyun;
    • Lee, Ji-Hyun;
    • Sohn, Sang Kyun;
    • Song, Ik-Chan;
    • Lee, Hong-ghi;
    • Cheong, Jung-Won;
    • Choi, Yunsuk;
    • Shin, Ho-Jin;
    • Lee, Se-ryeon;
    • Lee, Seok;
    • Yoon, Jae-Ho;
    • Lee, Hyewon;
    • Bang, Soo-Mee;
    • Koh, Youngil;
    • Park, Silvia;
    • Kim, Dae Sik;
    • Yhim, Ho-Young
    Publication type:
    Article
    48
    49
    50